Establishment of radiotherapy combined with antisense bcl-2 oligodeoxynucleotide in prostate cancer
Establishment of radiotherapy combined with antisense bcl-2 oligodeoxynucleotide in prostate cancer
批准号:
13671674
负责人:
MARUMO Ken
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
Bc1-2已被证明通过阻断细胞凋亡延长癌细胞存活,并具有清除活性氧的功能。反义bc1-2寡脱氧核苷酸(bc1-2 AS ODN)在PC-3细胞和JCA-1细胞中产生剂量依赖性细胞毒性和凋亡增加和bc1-2蛋白表达剂量依赖性降低。bcl-2 AS ODN显著增强了辐射对JCA-1细胞的细胞毒性,通过集落形成实验评估,与对照组(bcl-2感ODN或阳离子脂质)相比,己烯雌酚(DES)显著抑制PC-3细胞的生长,并呈剂量依赖性,显著诱导活性氧(ROS)的产生。反义bc1-2寡脱氧核苷酸显著增强des诱导的细胞毒性。bc1-2 AS ODN与DES联合使用比单独使用bc1-2 AS ODN和单独使用DES诱导的凋亡细胞明显增加。Buthionine sulphoximine (BSO)是一种谷胱甘肽消耗物,可显著降低细胞内谷胱甘肽浓度,增强des诱导的PC-3细胞毒性和ROS。bc1-2 AS ODN处理既不影响ROS的生成,也不影响细胞内谷胱甘肽浓度。综上所述,bc1-2 AS ODN通过凋亡途径显著增强了des诱导的非激素依赖性前列腺癌细胞的细胞毒性,而不需要增加活性氧的产生,而谷胱甘肽消耗物则增强了其细胞毒性和活性氧的产生
英文摘要
Bc1-2 has been shown to prolong cancer cell survival by blocking apoptosis and to have the function of scavenging reactive oxygen species. Antisense bc1-2 oligodeoxynucleotides (bc1-2 AS ODN) produced dose-dependent increases in cytotoxicity and apoptosis and a dose-dependent decrease in Bc1-2 protein expression in PC-3 cells and JCA-1 cells. Bc1-2 AS ODN significantly augmented the cytotoxicity induced by radiation on JCA-1 cells, which was assessed by the colony forming assay, when compared with controls (bcl-2 sense ODN or cationic lipid)Diethylstilbestrol (DES) significantly inhibited cell growth in PC-3 cells in a dose dependent fashion and significantly induced reactive oxygen species (ROS) generation. Antisense bc1-2 oligodeoxynucleotides significantly enhanced DES-induced cytotoxicity. A significant increase in apoptotic cells was induced by the combination of bc1-2 AS ODN and DES when compared with bc1-2 AS ODN alone and DES alone. Buthionine sulphoximine (BSO), which is a glutathione depletor, significantly decreased the intracellular concentration of glutathione and augmented the DES-induced cytotoxicity and ROS in PC-3 cells. Neither the generation of ROS nor the intracellular concentration of glutathione was influenced by bc1-2 AS ODN treatment. In conclusion, bc1-2 AS ODN significantly enhanced DES-induced cytotoxicity on hormone-independent prostate cancer cells through the apoptotic pathway, independently of an augmentation of reactive oxygen species generation, whereas the glutathione depletor augments its cytotoxicity and reactive oxygen species generation
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Eiji Kikuch et al.: "Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice"Cancer Res. 63. 107-110 (2003)
Eiji Kikuch 等人:“新型核因子 kappaB 抑制剂在裸鼠体内抑制激素难治性前列腺癌”Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kikuchi,Eiji, Nakashima,Jun, Horiguchi,Yutaka, Oya,Mototsugu, Ohigashi,Takashi, Murai,Masaru: "Enhancement of diethylstilbestrol induced cytotoxicity by bcl-2 antisense oligodeoxynucleotides and a glutathione depletor for prostate cancer"J Urol. 169. 730-
Kikuchi、Eiji、Nakashima、Jun、Horiguchi、Yutaka、Oya、Mototsugu、Ohigashi、Takashi、Murai、Masaru:“bcl-2 反义寡脱氧核苷酸和谷胱甘肽消耗剂对前列腺癌增强己烯雌酚诱导的细胞毒性”J Urol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Eiji Kikuchi et al.: "Enhancement of diethystilbestrol induced cytotoxicity by bcl-2antisense oligodeoxynucleotides and a glutathione depletor for prostate cancer"Journal of Urology. 169. 730-734 (2003)
Eiji Kikuchi 等人:“bcl-2 反义寡脱氧核苷酸和谷胱甘肽消耗剂对前列腺癌增强二乙雌酚诱导的细胞毒性”泌尿学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Eiji Kikuchi et al.: "Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice"Cancer Research. 63. 107-110 (2003)
Eiji Kikuchi 等人:“在裸鼠中通过新型核因子 kappaB 抑制剂抑制激素难治性前列腺癌”癌症研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kikuchi,E, Horiguchi,Y, Nakashima,J, Kuroda,K, Oya,M, Ohigashi,T, Takahashi,N, Shima,Y, Umezawa,K, Murai,M: "Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice"Cancer Res,. 63(1). 107-110 (2003)
Kikuchi,E, Horiguchi,Y, Nakashima,J, Kuroda,K, Oya,M, Ohigashi,T, Takahashi,N, Shima,Y, Umezawa,K, Murai,M:“抑制激素难治性前列腺癌
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
国内基金
海外基金
登录
查看更多内容
针刺强度通过调控Beclin-1/LC3与Bcl-2/Bax平衡促进面神经修复的量效机制研究
-
批准号:2026JJ82043
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张珂胜
-
依托单位:
非小细胞肺癌光诊疗中靶向Bcl-2新型PROTAC荧光探针的构建与评价
-
批准号:QN25H300004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:胡壮
-
依托单位:
SENP1介导急性髓系白血病对BCL-2抑制剂耐药的机制研究
-
批准号:2025JJ50476
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张简
-
依托单位:
黄芩苷上调Bcl-XL/Bcl-2通过Nrf2-GPX4通路抑制铁死亡减轻大鼠肠道缺血再灌注损伤
-
批准号:2025JJ81028
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:翟溶凡
-
依托单位:
靶向 MLL-Menin 和 BCL-2 协同抑制 TIFAB 进
而平衡经典和非经典 NF-κB 通路治疗
MLLr-AML
-
批准号:Q24H080020
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:凌清
-
依托单位:
Bcl-2原位成像的 AIE 呫吨酮碳苷分子探针挖掘及肿瘤早
期诊断研究
-
批准号:2024JJ8119
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:施树云
-
依托单位:
Bcl-2通过 p21 及 p53 通路调控细胞增殖与凋亡参与动脉粥样硬化的机制研究
-
批准号:2024JJ7350
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:江涛
-
依托单位:
HMGA2调节DNA甲基化水平介导BCL-2上调促进肺癌对奥希替尼耐
药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:戴富强
-
依托单位:
NSUN4通过抑制p53信号通路在弥漫大B细胞淋巴瘤BCL-2抑制剂耐药中的作用及分子机制研究
-
批准号:82300213
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:史远飞
-
依托单位:
CXCL1/CXCR2信号轴上调Bcl-2促进筋膜定植巨噬细胞迁移在皮下脂肪组织原位再生中的机制研究
-
批准号:82360615
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:毕鑫
-
依托单位: